Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
The Lancet. Oncology|April 12, 2003
Renal-cell carcinoma: tumour markers, T-cell epitopes, and potential for new therapiesAgnieszka Michael, Hardev S PandhaFuture Oncology (London, England)|November 3, 2011
Antiangiogenic effects of zoledronate on cancer neovasculatureStephen Metcalf, Hardev S Pandha, Richard MorganIndian Journal of Urology : IJU : Journal of the Urological Society of India|February 16, 2017
Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinomaRidhima Iyer, Bruce Montgomery, Hardev S PandhaMolecular Cancer|November 3, 2006
Calcium insensitivity of FA-6, a cell line derived from a pancreatic cancer associated with humoral hypercalcemia, is mediated by the significantly reduced expression of the Calcium Sensitive Receptor transduction component p38 MAPKRichard Morgan, Benjamin Fairfax, Hardev S PandhaInternational Journal of Cancer|January 26, 2022
Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancerRichard Morgan, Keith Hunter, Hardev S PandhaCancer Immunology, Immunotherapy : CII|November 17, 2011
Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?Gary W Middleton, Nicola E Annels, Hardev S PandhaBJU International|May 17, 2005
Immunotherapy of murine prostate cancer using whole tumour cells killed ex vivo by cytosine deaminase/5-fluorocytosine suicide-gene therapyHardev S Pandha, Dorthe Cook, Rebecca Greenhalgh, et al.Cancer Metastasis Reviews|March 24, 2005
Gene therapy for head and neck cancerKevin J Harrington, Christopher M Nutting, Hardev S PandhaCancers|April 13, 2019
Kinase Regulation of HOX Transcription FactorsMonika Primon, Keith D Hunter, Hardev S Pandha, et al.Pageof 7